Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

GI14-186

A Multi-Center, Single Arm, Phase II study of Pembrolizumab (MK-3475) in Combination with Chemotherapy for Patients with Advanced Colorectal Cancer: HCRN GI14-186

Status: Closed to Accrual

This is a multi-institutional, single arm, open-label, phase II study, including a safety run-in cohort. No randomization or blinding involved.

  • Condition: Colorectal Cancer
  • Intervention:
    • Drug: Pembrolizumab
    • Drug: mFOLFOX6
  • Phase: Phase 2

For full description, see www.clinicaltrials.gov.

Read news release about this trial.

Watch a video about this trial:

Project Manager: Dana Musapatika, dmusapatika@hoosiercancer.org; (317) 634-5842, ext. 39.